Selective androgen receptor modulator RAD140 is neuroprotective in cultured neurons and kainate-lesioned male rats

Endocrinology

Volumn 155, Issue 4, 2014, Pages 1398-1406

  Jayaraman, Anusha ^a   Christensen, Amy ^a   Moser, V Alexandra ^a   Vest, Rebekah S ^a   Miller, Chris P ^b   Hattersley, Gary ^b   Pike, Christian J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Radius Health Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; KAINIC ACID; NEUROPROTECTIVE AGENT; RAD 140; SELECTIVE ANDROGEN RECEPTOR MODULATOR; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DAMAGE; CELL DEATH; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG EFFICACY; EMBRYO; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; HIPPOCAMPAL NEURONAL CULTURE; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; YOUNG ADULT;

ACETANILIDES; ANIMALS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; FEMALE; HIPPOCAMPUS; HORMONE ANTAGONISTS; KAINIC ACID; MALE; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RISK; SIGNAL TRANSDUCTION;

EID: 84897890483     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1725     Document Type: Article

References (73)

1. Holland J, Bandelow S, Hogervorst E. Testosterone levels and cognition in elderly men: a review. Maturitas. 2011;69:322-337.
2. Morley JE. Testosterone replacement and the physiologic aspects of aging in men. Mayo Clin Proc. 2000;75(Suppl):S83-S87.
3. Hogervorst E, Combrinck M, Smith AD. Testosterone and gonadotropin levels in men with dementia. Neuro Endocrinol Lett. 2003;24:203-208. (Pubitemid 37074814)
4. Fuller SJ, Tan RS, Martins RN. Androgens in the etiology of Alzheimer's disease in agingmenand possible therapeutic interventions. J Alzheimers Dis. 2007;12:129-142. (Pubitemid 47509371)
5. Rosario ER, Chang L, Head EH, Stanczyk FZ, Pike CJ. Brain levels of sex steroid hormones in men andwomenduring normal aging and in Alzheimer's disease. Neurobiol Aging. 2011;32:604-613.
6. Rosario ER, Chang L, Stanczyk FZ, Pike CJ. Age-related testosterone depletion and the development of Alzheimer disease. JAMA. 2004;292:1431-1432. (Pubitemid 39258334)
7. Moffat SD, Zonderman AB, Metter EJ, et al. Free testosterone and risk for Alzheimer disease in older men. Neurology. 2004;62:188-193. (Pubitemid 38167123)
8. Rosario ER, Carroll JC, Oddo S, LaFerla FM, Pike CJ. Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease. J Neurosci. 2006;26:13384-13389. (Pubitemid 46011649)
9. Rosario ER, Carroll JC, Pike CJ. Evaluation of the effects of testosterone and luteinizing hormone on regulation of β-amyloid in male 3xTg-AD mice. Brain Res. 2012;1466:137-145.
10. McAllister C, Long J, Bowers A, et al. Genetic targeting aromatase in male amyloid precursor protein transgenic mice down-regulates β-secretase (BACE1) and prevents Alzheimer-like pathology and cognitive impairment. J Neurosci. 2010;30:7326-7334.
11. Gouras GK, Xu H, Gross RS, et al. Testosterone reduces neuronal secretion of Alzheimer's β-amyloid peptides. Proc Natl Acad Sci USA. 2000;97:1202-1205. (Pubitemid 30080836)
12. Yao M, Nguyen TV, Rosario ER, Ramsden M, Pike CJ. Androgens regulate neprilysin expression: role in reducing β-amyloid levels. J Neurochem. 2008;105:2477-2488. (Pubitemid 351782277)
13. Leranth C, Hajszan T, MacLusky NJ. Androgens increase spine synapse density in the CA1 hippocampal subfield of ovariectomized female rats. J Neurosci. 2004;24:495-499. (Pubitemid 38112381)
14. MacLusky NJ, Hajszan T, Prange-Kiel J, Leranth C. Androgen modulation of hippocampal synaptic plasticity. Neuroscience. 2006;138:957-965.
15. Kay JN, Hannigan P, Kelley DB. Trophic effects of androgen: development and hormonal regulation of neuron number in a sexually dimorphic vocal motor nucleus. J Neurobiol. 1999;40:375-385. (Pubitemid 29382863)
16. Spritzer MD, Galea LA. Testosterone and dihydrotestosterone, but not estradiol, enhance survival of new hippocampal neurons in adult male rats. Dev Neurobiol. 2007;67:1321-1333. (Pubitemid 47242759)
17. Janowsky JS. The role of androgens in cognition and brain aging in men. Neuroscience. 2006;138:1015-1020.
18. Pike CJ, Nguyen TV, Ramsden M, Yao M, Murphy MP, Rosario ER. Androgen cell signaling pathways involved in neuroprotective actions. Horm Behav. 2008;53:693-705.
19. Bruchovsky N, Wilson JD. The conversion of testosterone to 5-α-androstan-17-β-ol-3-one by rat prostate in vivo and in vitro. J Biol Chem. 1968;243:2012-2021.
20. Singh SM, Gauthier S, Labrie F. Androgen receptor antagonists (antiandrogens): structure-activity relationships. Current Med Chem. 2000;7:211-247. (Pubitemid 30396447)
21. Wright AS, Douglas RC, Thomas LN, Lazier CB, Rittmaster RS. Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase. Endocrinology. 1999;140:4509-4515. (Pubitemid 30666115)
22. Frye CA, McCormick CM. The neurosteroid, 3α-androstanediol, prevents inhibitory avoidance deficits and pyknotic cells in the granule layer of the dentate gyrus induced by adrenalectomy in rats. Brain Res. 2000;855:166-170. (Pubitemid 30067709)
23. Gooren LJ, Toorians AW. Significance of oestrogens in male (patho)physiology. Ann Endocrinol(Paris). 2003;64:126-135. (Pubitemid 36565169)
24. Azcoitia I, Sierra A, Veiga S, Honda S, Harada N, Garcia-Segura LM. Brain aromatase is neuroprotective. J Neurobiol. 2001;47:318-329. (Pubitemid 32467339)
25. Garcia-Segura LM, Wozniak A, Azcoitia I, Rodriguez JR, Hutchison RE, Hutchison JB. Aromatase expression by astrocytes after brain injury: implications for local estrogen formation in brain repair. Neuroscience. 1999;89:567-578. (Pubitemid 29044337)
26. Barreto G, Veiga S, Azcoitia I, Garcia-Segura LM, Garcia-Ovejero D. Testosterone decreases reactive astroglia and reactive microglia after brain injury in male rats: role of its metabolites, oestradiol and dihydrotestosterone. Eur J Neurosci. 2007;25:3039-3046. (Pubitemid 46888812)
27. Goodenough S, Engert S, Behl C. Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway. Neurosci Lett. 2000;296:49-52.
28. Rosario ER, Carroll J, Pike CJ. Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways. Brain Res. 2010;1359:281-290.
29. Pike CJ, Carroll JC, Rosario ER, Barron AM. Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol. 2009;30:239-258.
30. Jones JO. Improving selective androgen receptor modulator discovery and preclinical evaluation. Expert Opin Drug Discov. 2009;4:981-993.
31. Narayanan R, Mohler ML, Bohl CE, Miller DD, Dalton JT. Selective androgen receptor modulators in preclinical and clinical development. Nucl Recept Signal. 2008;6:e010.
32. Rosen J, Negro-Vilar A. Novel, non-steroidal, selective androgen receptor modulators (SARMs) with anabolic activity in bone and muscle and improved safety profile. J Musculoskelet Neuronal Interact. 2002;2:222-224. (Pubitemid 34223808)
33. Yarrow JF, Conover CF, McCoy SC, et al. 17β-Hydroxyestra-4,9,11- trien-3-one (trenbolone) exhibits tissue selective anabolic activity: effects on muscle, bone, adiposity, hemoglobin, and prostate. Am J Physiol Endocrinol Metab. 2011;300:E650-660.
34. LaMorte A, Kumar N, Bardin CW, Sundaram K. Aromatization of 7 α-methyl-19-nortestosterone by human placental microsomes in vitro. J Steroid Biochem Mol Biol. 1994;48:297-304.
35. Bhasin S, Jasuja R. Selective androgen receptor modulators as function promoting therapies. Curr Opin Clin Nutr Metab Care. 2009;12:232-240.
36. Miller CP, Shomali M, Lyttle CR, et al. Design, synthesis, and preclinical characterization of the selective androgen receptor modulator (SARM) RAD140. ACS Med Chem Lett. 2011;2:124-129.
37. Wang Q, Yu S, Simonyi A, Sun GY, Sun AY. Kainic acid-mediated excitotoxicity as a model for neurodegeneration. Mol Neurobiol. 2005;31:3-16. (Pubitemid 41271190)
38. Ramsden M, Shin TM, Pike CJ. Androgens modulate neuronal vulnerability to kainate lesion. Neuroscience. 2003;122:573-578. (Pubitemid 37410278)
39. Pike CJ. Estrogen modulates neuronal Bcl-xL expression and β-amyloid-induced apoptosis: relevance to Alzheimer's disease. J Neurochem. 1999;72:1552-1563. (Pubitemid 29140828)
40. Nguyen TV, Yao M, Pike CJ. Androgens activate mitogen-activated protein kinase signaling: role in neuroprotection. J Neurochem. 2005;94:1639-1651. (Pubitemid 41324645)
41. Gray LE Jr, Furr J, Ostby JS. Hershberger assay to investigate the effects of endocrine-disrupting compounds with androgenic or antiandrogenic activity in castrate-immature male rats. Curr Protoc Toxicol. 2005;Chapter 16:Unit 16.9.
42. Sperk G. Kainic acid seizures in the rat. Prog Neurobiol. 1994;42:1-32. (Pubitemid 24026117)
43. Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol. 1972;32:281-294.
44. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Δ Δ C(T)) Method. Methods. 2001;25:402-408. (Pubitemid 34164012)
45. West MJ, Slomianka L, Gundersen HJ. Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. Anat Rec. 1991;231:482-497.
46. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience. 1985;14:375-403. (Pubitemid 15169910)
47. Pike CJ. Testosterone attenuates β-amyloid toxicity in cultured hippocampal neurons. Brain Res. 2001;919:160-165. (Pubitemid 33016600)
48. Nguyen TV, Jayaraman A, Quaglino A, Pike CJ. Androgens selectively protect against apoptosis in hippocampal neurones. J Neuroendocrinol. 2010;22:1013-1022.
49. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000;351:95-105.
50. Wu D, Gore AC. Changes in androgen receptor, estrogen receptor α, and sexual behavior with aging and testosterone in male rats. Horm Behav. 2010;58:306-316.
51. Narayanan R, Coss CC, Yepuru M, Kearbey JD, Miller DD, Dalton JT. Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate androgen receptor function through distinct genomic and nongenomic signaling pathways. Mol Endocrinol. 2008;22:2448-2465.
52. Yarrow JF, McCoy SC, Borst SE. Tissue selectivity and potential clinical applications of trenbolone (17β-hydroxyestra-4,9,11-trien-3-one): a potent anabolic steroid with reduced androgenic and estrogenic activity. Steroids. 2010;75:377-389.
53. Bohl CE, Miller DD, Chen J, Bell CE, Dalton JT. Structural basis for accommodation of nonsteroidal ligands in the androgen receptor. J Biol Chem. 2005;280:37747-37754. (Pubitemid 41642384)
54. Allan G, Sbriscia T, Linton O, et al. A selective androgen receptor modulator with minimal prostate hypertrophic activity restores lean body mass in aged orchidectomized male rats. J Steroid Biochem Mol Biol. 2008;110:207-213.
55. Dalton JT, Barnette KG, Bohl CE, et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle. 2011;2:153-161.
56. Acevedo SE, McGinnis G, Raber J. Effects of 137Cs γ irradiation on cognitive performance and measures of anxiety in Apoe-/- and wild-type female mice. Radiat Res. 2008;170:422-428.
57. Dayger C, Villasana L, Pfankuch T, Davis M, Raber J. Effects of the SARM ACP-105 on rotorod performance and cued fear conditioning in sham-irradiated and irradiated female mice. Brain Res. 2011;1381:134-140.
58. Falkenstein E, Wehling M. Nongenomically initiated steroid actions. Eur J Clin Invest. 2000;30(Suppl 3):51-54. (Pubitemid 32154551)
59. Peterziel H, Mink S, Schonert A, Becker M, Klocker H, Cato AC. Rapid signalling by androgen receptor in prostate cancer cells. Oncogene. 1999;18:6322-6329.
60. Kousteni S, Bellido T, Plotkin LI, et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell. 2001;104:719-730. (Pubitemid 32241022)
61. Pollard H, Charriaut-Marlangue C, Cantagrel S, et al. Kainate-induced apoptotic cell death in hippocampal neurons. Neuroscience. 1994;63:7-18. (Pubitemid 24333948)
62. Bajetto A, Barbero S, Bonavia R, et al. Stromal cell-derived factor-1α induces astrocyte proliferation through the activation of extracellular signal-regulated kinases 1/2 pathway. J Neurochem. 2001;77:1226-1236. (Pubitemid 32523675)
63. Qui MS, Green SH. PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity. Neuron. 1992;9:705-717.
64. Krapivinsky G, Krapivinsky L, Manasian Y, et al. The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. Neuron. 2003;40:775-784. (Pubitemid 37431037)
65. Alonso M, Viola H, Izquierdo I, Medina JH. Aversive experiences are associated with a rapid and transient activation of ERKs in the rat hippocampus. Neurobiol Learn Mem. 2002;77:119-124. (Pubitemid 34971547)
66. Nguyen TV, Yao M, Pike CJ. Dihydrotestosterone activates CREB signaling in cultured hippocampal neurons. Brain Res. 2009;1298:1-12.
67. Hamson DK, Wainwright SR, Taylor JR, Jones BA, Watson NV, Galea LA. Androgens increase survival of adult born neurons in the dentate gyrus by an androgen receptor dependent mechanism in male rats. Endocrinology. 2013;154:3294-3304
68. Kim DH, Lilliehook C, Roides B, et al. Testosterone-induced matrix metalloproteinase activation is a checkpoint for neuronal addition to the adult songbird brain. J Neurosci. 2008;28:208-216.
69. Li M, Masugi-Tokita M, Takanami K, Yamada S, Kawata M. Testosterone has sublayer-specific effects on dendritic spine maturation mediated by BDNF and PSD-95 in pyramidal neurons in the hippocampus CA1 area. Brain Res. 2012;1484:76-84.
70. Balthazart J, Castagna C, Ball GF. Aromatase inhibition blocks the activation and sexual differentiation of appetitive male sexual behavior in Japanese quail. Behav Neurosci. 1997;111:381-397. (Pubitemid 27169328)
71. Hijazi RA, Cunningham GR. Andropause: is androgen replacement therapy indicated for the aging male? Annu Rev Med. 2005;56:117-137. (Pubitemid 40305274)
72. Estrada M, Varshney A, Ehrlich BE. Elevated testosterone induces apoptosis in neuronal cells. J Biol Chem. 2006;281:25492-25501. (Pubitemid 44401938)
73. Caraci F, Pistarà V, Corsaro A, et al. Neurotoxic properties of the anabolic androgenic steroids nandrolone and methandrostenolone in primary neuronal cultures. J Neurosci Res. 2011;89:592-600.